172
Views
0
CrossRef citations to date
0
Altmetric
Oncology

IER5L is a Prognostic Biomarker in Pan-Cancer Analysis and Correlates with Immune Infiltration and Immune Molecules in Non-Small Cell Lung Cancer

, , , , , & show all
Pages 5889-5908 | Received 18 Sep 2023, Accepted 01 Dec 2023, Published online: 12 Dec 2023